Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
Published on: May 10, 2024
Understanding Non-Small-Cell Lung Cancer: Biology, Therapeutics and Drug Resistance
Pankaj Ahluwalia1, Ravindra Kolhe1, Mumtaz Rojiani2,3
1Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Lung cancer is a major global health threat. This study investigates new therapeutic strategies to improve patient outcomes and reduce mortality rates.
Area of Science:
- Oncology
- Pulmonology
- Medical Research
Background:
- Lung cancer is the leading cause of cancer mortality worldwide.
- Significant unmet needs exist in current treatment paradigms.
- Advances in understanding lung cancer biology are crucial.
Related Concept Videos
Treatment Resistant Cancers
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Affecting Factors
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Therapeutic Drug Monitoring: Overview and Classification

